Home
About
Overview
Sharing Data
ORCID
Help
History (31)
Infant Nutrition Disorders
Controlled Before-After Studies
Celiac Disease
Perflubron reduces lung inflammation in respiratory syncytial virus infection by inhibiting chemokine expression and nuclear factor-kappa B activation.
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting.
See All 31 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting.
'Glycaemic variability': a new therapeutic challenge in diabetes and the critical care setting. Diabet Med. 2010 Aug; 27(8):862-7.
View in:
PubMed
subject areas
Blood Glucose
Critical Care
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2
Glycated Hemoglobin A
Humans
Hypoglycemia
Hypoglycemic Agents
Oxidative Stress
Prognosis
Risk Factors
authors with profiles
Michael Ihnat